About
William Avery
CPA, CA, CPA (NY)
An experienced and dynamic financial professional with breadth across technology, manufacturing, retail and biotech — and depth in public-company reporting, governance and capital markets.
Experience
Experienced Senior Leadership, by design.
2024 — Present
CFO, PharmAla Biotech Holdings Inc.
Acting CFO for a publicly listed biotech company.
2024 — Present
CFO, Jaguar Uranium Corp.
Publicly listed on the NYSE American - February 2026
2025 — Present
CFO, ICG Silver & Gold Ltd.
Publicly listed on the CSE - March 2026
2023 — Present
Founder, Avery Professional Corporation
Go-public, transaction readiness, CFO services and CFO support.
2014 — 2023
Partner, MNP LLP
Regional Public Companies Leader (2018–2023). Grew Toronto practice from $14M to $35M in revenue.
2008
Secondment, Moore Stephens Australia
First exposure to IFRS.
2005 — 2014
MNP LLP
Audit and assurance for public and private companies.
Industry knowledge
Sector depth.
Technology
Digital advertising · SAAS · E-commerce · Gaming, software & app development
Manufacturing
Agriculture (wine & cannabis) · Co-manufacturing (cannabis, food & beverage) · Bio-tech products
Retail
Wine & cannabis
Biotech & Life Sciences
Public company reporting and capital markets
Credentials
- 2012CPA, NY — New York, United States
- 2007CPA, CA — Canada
- 2005University of Waterloo
Speaking & thought leadership
- 2022IPO Readiness — TechTO panel, Moderator
- 2020AI & The Future of Finance — Presenter
- 2016 — 2023MNP Exchange Series — Content lead and presenter
Interested in working together — or considering William for a Board seat?